DSIJ Mindshare

The shares of Natco Pharma climbed over 10 per cent intraday on May 24, 2021, following the Drug Controller General of India (DCGI) approval to begin production of antifungal drug Amphotericin B liposomal injection, which is believed to be critical in the treatment of Mucormycosis, also called 'Black Fungus'. 

Zydus Cadila, a leading pharmaceutical company, announced this morning the launch of Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) under the brand name of ‘Ujvira’.  

The stock of ITC is trading in the range for a long period. To take advantage of this range-bound movement. 

On the options’ front, the 15,200 Put option strike has seen addition of nearly 19.16 lakh shares and the maximum open interest concentration on the put side stands at 15,000 strike. 

Cipla Limited, a leading pharmaceutical company announced today that it is going to distribute an anti-body of Casirivimab and Imdevimab drugs across India.  This anti-body cocktail is a product of Roche Pharma India.